Nantahala Capital Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-16,408
Closed -$1.02M 130
2021
Q1
$853K Sell
16,408
-548,251
-97% -$27.7M 0.02% 110
2020
Q4
$22.5M Sell
564,659
-217,566
-28% -$7.02M 0.7% 39
2020
Q3
$19.2M Sell
782,225
-1,462,899
-65% -$37.4M 0.59% 36
2020
Q2
$40.7M Buy
2,245,124
+113,953
+5% +$2.25M 1.23% 18
2020
Q1
$30.7M Buy
2,131,171
+1,029,257
+93% +$29.5M 1.15% 24
2019
Q4
$41.9M Sell
1,101,914
-900,000
-45% -$27M 1.29% 22
2019
Q3
$44.3M Sell
2,001,914
-470,000
-19% -$10M 1.64% 19
2019
Q2
$51.1M Buy
2,471,914
+350,802
+17% +$8.09M 1.57% 20
2019
Q1
$61.2M Sell
2,121,112
-352,000
-14% -$8.69M 1.91% 14
2018
Q4
$42.4M Buy
2,473,112
+364,709
+17% +$8.83M 1.3% 20
2018
Q3
$60M Buy
2,108,403
+504,078
+31% +$16.6M 1.61% 17
2018
Q2
$53.9M Sell
1,604,325
-54,375
-3% -$1.69M 2.18% 12
2018
Q1
$40.2M Buy
1,658,700
+11,500
+0.7% +$229K 1.81% 16
2017
Q4
$25M Buy
+1,647,200
New +$23.2M 1.11% 23

Other funds holding THC

Nantahala Capital Management's THC Position: Q2 2021 in Review

Nantahala Capital Management sold out of Tenet Healthcare (THC) in Q2 2021, closing a stake of 16,408 shares — an estimated $1.02M sold.

Nantahala Capital Management first reported a position in THC in Q4 2017 and held it in 14 quarters. The position peaked at $61.2M in Q1 2019. 322 funds tracked by Wall St. Rank hold THC as of Q2 2021.

  • Nantahala Capital Management reported no remaining Tenet Healthcare position as of Q2 2021 after selling out during the quarter.
  • Nantahala Capital Management sold 16,408 Tenet Healthcare shares in Q2 2021, an estimated $1.02M.
  • Nantahala Capital Management first reported a position in Tenet Healthcare in Q4 2017 and held it in 14 quarters.
  • Nantahala Capital Management's Tenet Healthcare position peaked at $61.2M in Q1 2019.
  • 322 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2021.

Based on Nantahala Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.